OxMIF Detection via Air-Drying and Idiotypic Antibodies
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting oxidized macrophage migration inhibitory factor (oxMIF) in tissues are hindered by structural changes and high background noise, making it difficult to reliably detect oxMIF and anti-oxMIF antibodies, especially in tissues treated with anti-oxMIF antibodies.
Innovation Solution
A method using specific monoclonal anti-oxMIF antibodies, such as RAB9, RAB0, and RAM9, and idiotypic monoclonal rabbit antibodies, which are designed to preserve the native structure of oxMIF and minimize background noise through an immunohistochemistry protocol that avoids fixation steps and uses air-drying, allowing for sensitive and specific detection of oxMIF and anti-oxMIF antibodies in tissue sections.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If standard immunohistochemistry fixation steps are used, then tissue structure is preserved, but oxMIF detection precision deteriorates due to structural changes and high background noise
Solution Approach 1:
The patent removes the fixation step from the standard immunohistochemistry protocol. By extracting this harmful processing step, the native structure of oxMIF is preserved in the tissue sections, eliminating the structural changes and background noise that fixation causes, thereby enabling precise detection of oxMIF and anti-oxMIF antibodies
Solution Approach 2:
The patent implements air-drying as a preliminary step before antibody incubation. This preliminary action stabilizes the tissue sections without causing the structural changes associated with chemical fixation, preparing the samples for subsequent specific antibody binding while maintaining oxMIF integrity
2Productivity
If standard immunohistochemistry protocols are used, then general tissue staining is achieved, but detection of anti-oxMIF antibodies in treated tissues becomes unreliable due to high background noise
Solution Approach 1:
The patent employs idiotypic monoclonal rabbit antibodies as intermediaries. These secondary antibodies specifically recognize the primary anti-oxMIF antibodies bound to oxMIF, creating a specific detection pathway that distinguishes true positive signals from background noise, even in tissues previously treated with anti-oxMIF antibodies
Solution Approach 2:
The patent changes the detection parameters by using air-dried sections instead of fixed sections. This parameter change eliminates the high background noise characteristic of fixed sections, thereby improving the reliability of detecting anti-oxMIF antibodies in treated tissues without sacrificing detection throughput
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables highly sensitive and specific detection of oxMIF and anti-oxMIF antibodies with reduced background noise, even in tissues previously treated with anti-oxMIF antibodies, providing a reliable marker for disease states like cancer.
Implementation Method 1
A method using specific monoclonal anti-oxMIF antibodies, such as RAB9, RAB0, and RAM9, and idiotypic monoclonal rabbit antibodies
Implementation Method 2
an immunohistochemistry protocol that avoids fixation steps and uses air-drying
Data Source
AI summary
The present invention pertains to the specific detection of MIF, in particular oxMIF, and of anti-oxMIF antibodies in tissues. A detection method is provided which uses immunohistochemistry or immunofluorescence and wherein specific anti-oxMIF antibodies and specific idiotypic monoclonal rabbit antibodies are used.